Facing a terminal cancer diagnosis, Steve wanted to do everything he could to ensure his wife and children didn’t lose their father, and he spent as much time as possible trying to “keep things as normal as possible.”
Steve’s wife, who was incredibly helpful throughout, began researching new therapies, looking for something that could help after all other treatments had failed. That’s when she came across CAR T-cell therapy, a form of immunotherapy that uses genetically engineered patient cells to kill cancer cells, offering a more targeted approach.
Finding a way through multiple myeloma
Through being involved in all of Steve’s care, doing research and joining various groups, Steve’s wife learned about CAR T cell therapy, and she brought it to his doctor to see if it was an option.
All the studies and research were promising, and with no options left, Steve and his family were willing to keep finding a new way to heal.
Unfortunately, however, Steve was not eligible for the trials that took place in Canada due to the unique presentation of his cancer. But there was a solution.
“In the United States they had already approved CAR-T as an option for people and because I had coverage through WSIB insurance, because myeloma is one of the cancers recognized as most likely to be caused by firefighters, preventive legislation paved the way for me to get treatment,” said Steve.
#Time #running #innovative #treatments #multiple #myeloma #reaching #patients